Francis Medical, Inc., a privately-held medical device company developing an innovative and proprietary water vapor ablation therapy for the treatment of prostate, kidney and bladder cancer, today ...
Attendees will gain insights into the NanoKnife System’s proprietary irreversible electroporation (IRE) technology and how it is poised to become the standard, function-preserving treatment for men ...
The presentation will be broadcast live and archived on the Company's website at www.profoundmedical.com under "Webcasts" in the Investors section. About Profound Medical Corp. Profound is a ...
The study found that Focal One's treatment methods match up with the gold star standard of surgery, and improve quality of life outcomes.
Compared to white men, Black men are at greater risk of prostate cancer, more likely to develop it earlier, and more likely to die from it. Earlier screening may be warranted. Dr. Sheel Patel ...
Treatment for lung cancer varies according to age, type of cancer, extent of disease, tolerance to medication and patient preference. Treatment options include a combination of surgery, radiation, ...
New research by a team of Indiana University School of Medicine scientists and their collaborators has uncovered a novel vulnerability in prostate cancer animal models that starves prostate tumors ...
The mention of any product, service, or therapy in this Data Supplement should not be construed as an endorsement ... State Key Laboratory of Oncology in South China, Collaborative Innovation Centre ...
Scientists at City of Hope ®, one of the largest and most advanced cancer research and treatment organizations in the U.S. with its National Medical Center named top 5 in the nation for cancer by ...
providing a new avenue for prostate cancer treatment. Prostate cancer remains a global health challenge, ranking as the second most commonly diagnosed cancer among men. Although treatments like ...
Data from the phase 2 CAPFISH-3 trial show that a high omega-3, low omega-6 diet supplemented with fish oil capsules significantly reduced proliferation of Ki-67, a biomarker for prostate cancer ...